Nathan Rich
Stock Analyst at Goldman Sachs
(0.32)
# 4,076
Out of 4,842 analysts
84
Total ratings
17.24%
Success rate
-32.71%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $13.80 | +52.17% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $167.14 | +17.27% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $16.33 | +83.71% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $7.29 | +9.81% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $18.46 | -5.20% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $230.08 | +67.33% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $13.52 | +3.55% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $17.53 | -37.25% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $183.05 | +22.92% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $515.45 | +26.10% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $62.78 | +40.17% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $14.90 | -19.44% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $71.95 | +18.15% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $8.83 | +24.58% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $303.87 | +10.24% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $298.17 | +79.43% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $13.80
Upside: +52.17%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $167.14
Upside: +17.27%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $16.33
Upside: +83.71%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $7.29
Upside: +9.81%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $18.46
Upside: -5.20%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $230.08
Upside: +67.33%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $13.52
Upside: +3.55%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $17.53
Upside: -37.25%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $183.05
Upside: +22.92%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $515.45
Upside: +26.10%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $62.78
Upside: +40.17%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $14.90
Upside: -19.44%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $71.95
Upside: +18.15%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $8.83
Upside: +24.58%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $303.87
Upside: +10.24%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $298.17
Upside: +79.43%